New proactive vaccine approach to bone cancer may help treat same cancer in dogs without the need of chemotherapy. If the treatment is effective, it might open some doors for the same treatment to be practiced on Humans.
In a first-of-its-kind study, scientists at the University of Missouri have helped advance a patient-specific, precision medicine treatment for bone cancer in dogs. By creating a vaccine from a dog's own tumor, scientists worked with ELIAS Animal Health to target specific cancer cells and avoid the toxic side effects of chemotherapy, while also opening the door for future human clinical trials.
After Surgery to Treat Rare Bone Cancer, the Surfing Pro Hits Back Waters
Richie Lovett, professional surfer, attributed his early hip pains at age 31, to his athletic lifestyle.
Advertisement
Osteosarcoma, or bone cancer, is not common in humans, representing only about 800-900 new cases each year in the U.S. About half of those cases are reported in children and teens. However, for dogs, this disease is much more common, with more than 10,000 cases a year occurring in the U.S.
"A vaccine is made out of the dog's own tumor for the dog's immune system to recognize," said Jeffrey Bryan, a professor of oncology at the MU College of Veterinary Medicine and director of Comparative Oncology Radiobiology and Epigenetics Laboratory. "The dogs received no chemotherapy and received only immunotherapy after their surgery. It's the first time that dogs with osteosarcoma have experienced prolonged survival without receiving chemotherapy, which is really exciting."
![Childhood Bone Cancers Grow Years Before They Are Diagnosed]( "Childhood Bone Cancers Grow Years Before They Are Diagnosed")
Children's bone cancers could remain hidden for years before diagnosis. Ewing sarcoma is a rare cancer found mainly in bone or soft tissue of teenagers and is the second most commonly diagnosed bone cancer in young people.
In the study, researchers partnered with ELIAS Animal Health to test a vaccine to treat osteosarcoma by using a dog's own lymphocytes. Overall, the dogs receiving this therapy had more than 400 days of remission compared to about 270 days for dogs receiving chemotherapy in a separate study by the National Cancer Institute.
"Lymphocytes are immune cells that recognize where pathogens are hiding in the body and then kill the cells harboring those pathogens," Bryan said. "After we remove the tumor, we create a vaccine using the dog's tumor cells to stimulate anti-tumor lymphocytes. These lymphocytes are then collected by apheresis and expanded outside the body by Elias Animal Health to create a transfusion of the patient's immune cells. These cells are activated and essentially really angry at whatever they are supposed to attack. When put back into the body, they should identify and destroy tumor cells. Ideally, this immune response would destroy every last tumor cell."
Mizzou researchers hope to continue immunotherapy discovery with dogs in order to optimize the new therapy for future human clinical trials with the hopes of treating osteosarcoma and other cancers, especially metastatic osteosarcoma in children.
They are currently continuing this work through another immunotherapy trial in progress with a grant by the Morris Animal Foundation through the National Cancer Institute Comparative Oncology Trials Consortium.
Source: Eurekalert
Childhood Bone Cancers Grow Years Before They Are Diagnosed
Children's bone cancers could remain hidden for years before diagnosis. Ewing sarcoma is a rare cancer found mainly in bone or soft tissue of teenagers and is the second most commonly diagnosed bone cancer in young people.
Advertisement
In the study, researchers partnered with ELIAS Animal Health to test a vaccine to treat osteosarcoma by using a dog's own lymphocytes. Overall, the dogs receiving this therapy had more than 400 days of remission compared to about 270 days for dogs receiving chemotherapy in a separate study by the National Cancer Institute.
"Lymphocytes are immune cells that recognize where pathogens are hiding in the body and then kill the cells harboring those pathogens," Bryan said. "After we remove the tumor, we create a vaccine using the dog's tumor cells to stimulate anti-tumor lymphocytes. These lymphocytes are then collected by apheresis and expanded outside the body by Elias Animal Health to create a transfusion of the patient's immune cells. These cells are activated and essentially really angry at whatever they are supposed to attack. When put back into the body, they should identify and destroy tumor cells. Ideally, this immune response would destroy every last tumor cell."
Mizzou researchers hope to continue immunotherapy discovery with dogs in order to optimize the new therapy for future human clinical trials with the hopes of treating osteosarcoma and other cancers, especially metastatic osteosarcoma in children.
They are currently continuing this work through another immunotherapy trial in progress with a grant by the Morris Animal Foundation through the National Cancer Institute Comparative Oncology Trials Consortium.
Source: Eurekalert
Bone Cancer in Children and Adolescents Shows Epigenetic Diversity
Ewing sarcoma tumors carry very few DNA mutations that could explain the observed differences in the disease course of Ewing sarcoma patients.
Advertisement
New Animal Model to Understand Metastasis in Bone CancerOrthotopic models are considered more clinically relevant and as it shows the interaction of tumor cells in its natural environment. | Advertisement
|
Advertisement
Recommended Reading
Latest Research News
Studies using brain scans shows that how our brain helps us experience and remember our daily surroundings.
Scientists explore a potential mechanism that a jawless fish called the lampreys employs to swim again after spinal cord injuries.
New study finds that lesbian, gay, and bisexual (LGB) preteens exhibit more social media and mobile phone addiction than straight peers.
The model for memory consolidation claims that the hippocampus forms new memories and, as time goes on, trains the cortex to store enduring memories.
A new study explored the link between T immune cells in ill patients and mortality risk.